These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4263756)

  • 1. [Clinical, autoimmunological and neuropathological aspects of multiple sclerosis. II].
    Prick JJ; Jaspar HH
    Proc K Ned Akad Wet C; 1972; 75(4):276-86. PubMed ID: 4263756
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical, autoimmunological and neuropathological aspects of multiple sclerosis. I].
    Prick JJ; Jaspar HH
    Proc K Ned Akad Wet C; 1972; 75(4):257-75. PubMed ID: 4263755
    [No Abstract]   [Full Text] [Related]  

  • 3. [Various aspects of immunopathogenesis of multiple sclerosis and therapeutic possibilities].
    Aleksandrowicz J; Blicharski J; Skotnicki A; Retinger M; Zduńczyk A
    Pol Tyg Lek; 1981 Aug; 36(35):1363-5. PubMed ID: 7036112
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial: Immunologic mysteries of multiple sclerosis.
    Waksman BH
    N Engl J Med; 1974 Jul; 291(1):45-6. PubMed ID: 4832403
    [No Abstract]   [Full Text] [Related]  

  • 5. The aetiology and pathogenesis of multiple sclerosis.
    Adams CW; Hallpike JF
    Guys Hosp Rep; 1969; 118(2):263-86. PubMed ID: 4896181
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosis.
    Dhib-Jalbut S
    Neurology; 2007 May; 68(22 Suppl 3):S13-21; discussion S43-54. PubMed ID: 17548563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prospects of an immunologic therapy of multiple sclerosis].
    Fasanaro G; Gentile A; Stella L
    Acta Neurol (Napoli); 1972; 27(4):367-78. PubMed ID: 5085161
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathology of multiple sclerosis.
    Seitelberger F
    Ann Clin Res; 1973 Oct; 5(5):337-44. PubMed ID: 4792208
    [No Abstract]   [Full Text] [Related]  

  • 9. [Interaction of central nervous system local immunity and systemic immunity during multiple sclerosis].
    Tourtellotte WW
    Rev Neurol (Paris); 1972 Nov; 127(5):497-504. PubMed ID: 4588993
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular "negativity" may underlie multiple sclerosis: role of the myelin basic protein family in the pathogenesis of MS.
    Musse AA; Harauz G
    Int Rev Neurobiol; 2007; 79():149-72. PubMed ID: 17531841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of autoimmunity in multiple sclerosis.
    Whitaker JN; Snyder DS
    CRC Crit Rev Clin Neurobiol; 1984; 1(1):45-82. PubMed ID: 6400508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroimmunology of multiple sclerosis and experimental allergic encephalomyelitis.
    Stuerzebecher S; Martin R
    Neuroimaging Clin N Am; 2000 Nov; 10(4):649-68 ,vii-viii. PubMed ID: 11359717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin reactions to myelin antigen and purified encephalitogenic factor in multiple sclerosis.
    Cendrowski W; Murawski K
    Arch Immunol Ther Exp (Warsz); 1966; 14(2):164-9. PubMed ID: 5914140
    [No Abstract]   [Full Text] [Related]  

  • 14. An in-vitro approach to the study of oligodendrocytes and their involvement in multiple sclerosis.
    Szuchet S; Dumas M
    Neurol Clin; 1983 Aug; 1(3):729-55. PubMed ID: 6680171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Will there soon be a sub-type specific treatment? New approaches to multiple sclerosis therapy].
    MMW Fortschr Med; 2008 Apr; 150(15):17. PubMed ID: 18510111
    [No Abstract]   [Full Text] [Related]  

  • 16. [Multiple sclerosis: new pathogenetic and diagnostic data].
    Woyciechowska J
    Neurol Neurochir Pol; 1987; 21(1):66-70. PubMed ID: 3302742
    [No Abstract]   [Full Text] [Related]  

  • 17. The peculiarities of the antibrain antibodies in multiple sclerosis and other diseases accompanied by myelin destruction.
    Gannushkina IV; Sukhorukova LI; Zavalishin IA
    Acta Neurol (Napoli); 1985; 7(3-4):323-7. PubMed ID: 4061144
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunobiology of oligodendrocytes in multiple sclerosis.
    Ruffini F; Chojnacki A; Weiss S; Antel JP
    Adv Neurol; 2006; 98():47-63. PubMed ID: 16400826
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence for pathogenic heterogeneity in multiple sclerosis.
    Lucchinetti CF; Bruck W; Lassmann H
    Ann Neurol; 2004 Aug; 56(2):308. PubMed ID: 15293289
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum antimyelin factors in experimental allergic encephalomyelitis and multiple sclerosis.
    Seil FJ; Agrawal HC
    Prog Clin Biol Res; 1984; 146():199-206. PubMed ID: 6201891
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.